COVID-19 Creating Growth Opportunities for Respiratory Drugs Market; Market to Cross USD 25,500 million by the End of 2027 Due to Soaring Burden of Chronic Respiratory Diseases Worldwide
January 12, 2021 08:08 ET
|
Research Nester
New York, Jan. 12, 2021 (GLOBE NEWSWIRE) -- With availability of limited preventive or therapeutic interventions for respiratory viruses resulting in morbidity and mortality globally, there is...